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Hydrostatic pressureMechanical forces are essential to the development and progression of ﬁbrosis, and are likely to be as important
as soluble factors. These forces regulate the phenotype and proliferation of myoﬁbroblasts and other cells in
damaged tissues, the activation of growth factors, the structure and mechanics of the matrix, and, potentially,
tissue patterning. Better understanding of the variety andmagnitude of forces, the characteristics of those forces
in biological tissues, and their impact on ﬁbrosis in multiple tissues is needed and may lead to identiﬁcation of
important new therapeutic targets. This article is part of a Special Issue entitled: Fibrosis: Translation of basic
research to human disease.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Mechanical forces are essential to the development, progression,
and (potentially) regression of tissue ﬁbrosis. Although often ignored
in studies and models of ﬁbrosis, particularly in the era of genomics
and proteomics, mechanical signals are similar to chemical signals
in their range of effects and are likely to be equally important. The
mechanical forces that act in ﬁbrosis are highly varied, and may
mediate individual cell phenotypes as well as global architectural
changes. Understanding the role of mechanics in ﬁbrosis is key to
understanding the basic pathophysiological mechanisms of ﬁbrotic
diseases as well as developing new therapies.2. Forces
There are multiple forces at work in tissues. These include tension
and compressive forces (forces which pull or push perpendicular to
the surface of an object) and shear forces (which are parallel to the
surface) (Fig. 1A). These forces exert stress on objects, deﬁned as force
(in Newtons (N)) normalized to the area over which it acts and
expressed in units of pascals (1 Pa=1 pN/μm2). Forces in tissues result
from cell-generated tension,ﬂuidﬂow, stretch, and hydrostatic/osmotic
pressure, which are resisted to variable extents by tissue stiffness. These
forces collectively regulate the phenotype and proliferation of
myoﬁbroblasts and other cells in damaged tissues, the activation ofs: Translation of basic research
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l rights reserved.growth factors, and the structure and mechanics of the matrix — all of
which are central to ﬁbrosis.
There are important differences between signaling frommechan-
ical (force-generated) stimuli and signaling from soluble (chemical)
stimuli [1]. Soluble signals, such as growth factors, diffuse radially and
provide limited directional information, while mechanical signals can
be highly directional and thereby convey complex information in
three dimensions. This is particularly important for cells of the same
type, which can communicate over long ranges viamechanical signals;
for autocrine soluble signals, cells cannot build up concentration gradi-
ents relative to their neighbors. Mechanical signals, which decay as a
function of 1/r (where r is the radius) when they are transmitted
through an elastic continuum and decay even more gradually when
transmitted directly through ﬁlamentous elements of the matrix, are
also communicated over longer length scales than soluble signals,
which decay as 1/r2. For example, some strains (deformations caused
by forces) can be transmitted over distances of hundreds of microns
[2]. Additionally, mechanical signals can be regulated rapidly. While
chemical signals require translation into second messenger cascades,
mechanical signals are often transmitted directly, without the need
for diffusible intermediates. Thus, force-mediated signals can be started
and stopped rapidly compared to soluble signals, allowing increased
control in time.
It is important to note that changes in the mechanical properties
of tissues, like changes in the level or distribution of soluble factors,
can both cause and result from ﬁbrosis. In the same way that
a proﬁbrogenic growth factor like transforming growth factor-β
(TGF-β) stimulates myoﬁbroblast activation and is then produced by
those samemyoﬁbroblasts, thereby perpetuating ﬁbrosis, myoﬁbroblasts
can be activated in response to mechanical forces and then perpetuate
ﬁbrosis by altering the mechanical environment.
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Fig. 1. Forces affecting tissues. A) Forces acting on tissues. B) The elastic modulus of a material is the slope of the stress (force per unit area) plotted against the strain (deformation).
The diagram demonstrates linear elasticity, where the stress/strain relationship is constant. In reality, most biological materials demonstrate non-linear elasticity, such that the elas-
tic modulus changes as strain increases.
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The best-studied force in tissue ﬁbrosis is tension generated in re-
sponse to tissue stiffness. Tissue stiffness is measured as the elastic
modulus, deﬁned as the resistance to deformation, and is expressed as
the magnitude of a stress (compression, elongation, or shear force, nor-
malized to area) divided by the strain (deformation) induced by the
stress (Fig. 1B). Young's elastic modulus (E) describes the resistance to
a compressive or elongating force, while the shear elastic modulus
(G) describes the resistance to a shear force. E and G are both expressed
in units of Pa; for a perfectly elasticmaterial that conserves volume (one
that returns to its original shape when the stress is removed), E is three
times G. Tissues, however, are not perfectly elastic but are viscoelastic,
meaning that, like liquids, they have a viscosity, and that the strain in
response to a stress changes with time [3,4]. Although the role of the
elastic modulus in regulating cell behavior is the subject of increasing
study, the role of the viscous component of tissues is poorly understood
[5]. Tissues are also structurally heterogeneous and resist deformation to
different extents depending on the direction in which a force is applied.
Additionally, neither the elastic nor the viscous stress of most biological
tissues varies linearly with strain; although this can be important in
maintaining themechanical characteristics and integrity of a given tissue,
it is difﬁcult to model and study [6].
Tissue stiffness is sensed when cells adhere to matrix proteins and
apply tension,meeting resistance that reﬂects the stiffness of the tissue.
The cellular actin–myosin cytoskeleton exerts tension on extracellular
matrix proteins via integrin attachments located within focal adhe-
sions; stiffer tissues result in increased resistance to the pulling force
exerted by cells, contributing to strengthening that force [7,8]. Whether
the mechanical force originating at the cell boundary is transmitted
directly to the nucleus or to nuclear proteins (Yap/Taz, for example)
[9], and whether signaling cascades are activated (potentially via focal
adhesion kinase (FAK) or other focal adhesion proteins) as a result of
tension at the site of the focal adhesion, are issues that have stimulated
extensive investigation [10].
Normal tissues vary in their stiffness when measured over the
same strains and time scales. The brain is very soft, with an elastic
modulus around 100 Pa; the liver, while also soft, is slightly stiffer
at 400–600 Pa, and the muscle and bone are stiffer still (104 and
106 Pa, respectively) [1]. It is clear from clinical practice that tissue
stiffness changes in disease states. In the same way that we can easily
tell by touch that a steel bar is stiffer than gelatin, palpation as part of
the routine physical exam enables detection of differences in skin or
liver stiffness and suggests that ﬁbrotic tissues are stiffer than normal
tissues. Multiple studies have shown that ﬁbrotic lungs become stiffer
in ﬁbrosis, with elastic modulus values ranging from approximately
2 kPa for normal tissue to approximately 17 kPa for ﬁbrotic tissue
[11–13]. We have found normal livers ex vivo to have a shear modulusless than 1 kPa, while ﬁbrotic livers range from 3 kPa to 22 kPa [14].
Transient elastography, which measures the elastic modulus, is wide-
ly used in clinical practice outside of the U.S. to assess the liver stiff-
ness in patients with liver disease; although values vary from one
study to the next, elastic moduli (measured at time scales that are
shorter than those generally used for ex vivo studies) are typically
less than 5 kPa for normal livers and greater than 12 kPa for cirrhotic
livers [15].
Organs with established ﬁbrosis are thought to be stiffer as a result
of their increased quantity of extracellular matrix, in particular ﬁbrillar
collagens. It appears, however, that increasedmatrix alone is unlikely to
account for increases in tissue stiffness in ﬁbrosis and that stiffness and
matrix quantity are not linearly related. Our studies suggest that in-
creases in collagen and elastin cross-linking account for some of the
increase in elastic modulus in liver ﬁbrosis and that the mechanical
properties of the injured liver change signiﬁcantly early after
injury, before signiﬁcant matrix deposition has occurred [14,16]. This
crosslinking appears to be initiated by lysyl oxidase family crosslinking
enzymes; the changes in stiffness are consistent with the effects of lysyl
oxidases in isolated collagen cushions, the vasculature, and different
cancers (see below) [17–21]. The contribution of altered cell (as op-
posed to matrix) stiffness to tissue mechanics in ﬁbrosis has not been
established but may be considerable [12].
4. Other forces acting on tissues
Forces other than tension generated in response to tissue stiffness
may also contribute to the development and progression of ﬁbrosis.
Tissues are subject to shear stress caused by ﬂuid ﬂow through the
vasculature, ducts, and interstitium. Of these, vascular ﬂow and the
effects of shear stress on the vascular endothelium are best understood,
in particular in the context of cardiovascular disease and remodeling
(a formof injury and ﬁbrosis, although not strictly speaking tissueﬁbro-
sis). Alterations in vessel geometry, ﬂow rate, and ﬂuid viscosity con-
tribute to changes in shear stress, regulating the release by endothelial
cells of growth factors, vasodilators like nitric oxide, and other soluble
factors, and leading to long-term changes in gene and protein expres-
sion [22]. Mechanotransduction results from cell surface deformation
(affecting ion channel function, cell surface receptors, the glycocalyx,
the primary cilia, and the physical properties of the membrane) as
well as the transmission of signals from the cell surface to distant re-
gions of the cell, affecting cell-substratum and cell–cell interactions
which in turn lead to changes in chemical signals [22,23]. Tissues such
as the kidney, liver, and lung have signiﬁcant amounts of ﬂow through
specialized vessels including the glomerulus in the kidney, sinusoids in
the liver, and pulmonary vessels in the lung. Altered ﬂow through these
vessels may be both the cause and the result of tissue remodeling and
ﬁbrosis, and may also result in pathologic angiogenesis [24].
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and renal tubules represents another source of shear stress in tissues
that may be relevant to ﬁbrosis [25]. The primary cilia appear to be
particularly important for mechanotransduction in these settings
[26] with genetic disorders of the primary cilia (including polycystic
kidney disease and nephronophthisis) leading to epithelial pathology
andﬁbrosis in the liver, kidney, andpancreas. Experimental data suggest
that altered shear stress in the renal tubules increases inﬂammation [27],
while altered shear stress in the glomerulus alters the actin cytoskeleton
[28], suggesting that the effects of shear stress in tissue ﬁbrosis may be
complex.
Interstitial ﬂuid ﬂow, the extremely slow ﬂow between capil-
laries and lymphatics (0.1–2 μm/s, compared to 10–20 cm/s for
ﬂow in blood vessels), is another important source of shear stress in
tissue ﬁbrosis. Interstitial ﬂow varies with inﬂammation and edema, the
amount and quality of the matrix (especially collagens and glycosamino-
glycans), the composition of the ﬂuid, and the size of lymphatics [29]; al-
tered ﬂow results in changes in growth factor release (including TGF-β),
collagen alignment, and myoﬁbroblast differentiation [30].
Other forces potentially operative in ﬁbrosis include hydrostatic
pressure, osmotic pressure, and stretch. These forces may be related
to ﬂow (pulsatile ﬂow, for example, causes stretch; elevated hydro-
static pressure results from obstructed ﬂow; and interstitial ﬂow is
driven by gradients in hydrostatic and osmotic pressure). Obstruction
of the bile ducts, pancreatic duct, and ureters leads to ﬁbrosis, likely
due at least in part to changes in shear stress (stasis) and hydrostatic
pressure [31]. The development of cardiac cirrhosis in response to
high central venous pressures suggests that elevations in hydrostatic
pressure are highly relevant to ﬁbrosis in vivo. Stretch is particularly
important in the lung, which is subject to cyclical stretch during res-
piration [32]. The pathways responsible for transducing these differ-
ent forces are still under investigation, although there is evidence
that cation channels in the transient receptor potential (TRP) family,
the actin-interacting protein zyxin, and G protein-coupled receptors
are activated in response to stretch [33,34] while ion channel activa-
tion and alterations in cytoskeletal stability are part of the response to
hydrostatic pressure [35].5. Integration of soluble and mechanical signals
Mechanical and soluble signals are often interdependent. Mechani-
cal forces can act both directly and indirectly on soluble factors.
TGF-β, which is arguably the most important soluble factor in ﬁbrosis,
undergoes activation as the direct result of mechanical tension
(Fig. 2). TGF-β is secreted as part of a latent complex and stored in the
ECM; one component of this latent complex, the latency-associated
peptide (LAP), binds directly to certain integrins, linking it to cells.
Hinz and co-workers, in a series of elegant experiments, demonstrated
that cells exert tension on the LAP through this integrin attachment. If
the matrix to which the cells and TGF-β complex are attached is soft,
it deforms in response to tension and the complex remains intact. If
the matrix is stiff, however, resistance to cell-generated tension results
in deformation of the LAP and release of active TGF-β [36,37]. For
myoﬁbroblasts, this increased TGF-β results in increasedα-smoothmus-
cle actin (α-SMA), which interacts with cellular myosin to contract and
produce increased tension — effectively a feed-forward loop incorporat-
ing both soluble andmechanical signals [37]. Thus, the stiffness of injured
and ﬁbrotic tissues may perpetuate ﬁbrosis via mechanically-regulated
increases in the amount of active TGF-β present. TGF-β is a common
factor downstream of many mechanical forces: in addition to tension,
other forces including interstitial ﬂuid ﬂow and stretch have been impli-
cated in TGF-β activation and release [30,38]. Similar mechanisms have
not yet been identiﬁed for other growth factors but many are also stored
in the matrix and may be activated or released in response to cell-
generated tension and matrix deformation [39].In addition to acting directly on growth factors, mechanical signals
can be converted to biochemical signals that intersect with or are part
of soluble factor signaling pathways [40–42]. In lung ﬁbroblasts, in-
creased stiffness causes inhibition of prostaglandin E(2), which pro-
motes ﬁbrosis [11]. Stiffness also enhances the response to exogenous
TGF-β [43]. NF-κB, which is downstream of many critical soluble factor
pathways in ﬁbrosis [44,45], is also downstream of some mechanical
forces. Wnt/β-catenin [46,47], interleukins, and (as discussed above)
G protein-coupled receptors and ion channels are common to both me-
chanical and soluble signaling pathways [41,42]. Integrins and their
downstream effector FAK are part of the cellular mechanotransduction
apparatus but they also transduce signals from soluble factors. In some
cases, integrins interact directly with soluble factors (for example,
vascular endothelial growth factor (VEGF)) and growth factor receptors
[48,49]. Speciﬁc interactions betweenmechanical and soluble factors in
ﬁbrosis need to be deﬁned.
6. The effects of mechanical forces on myoﬁbroblasts
Myoﬁbroblasts are the major ﬁbrogenic cells in all forms of tissue
ﬁbrosis. These cells, which are derived from precursor cells including
pericytes and ﬁbroblasts, express α-SMA de novo after injury, develop
stress ﬁbers, and generate contractile force, exerting tension on the sur-
roundingmatrix. The importance of mechanical forces tomyoﬁbroblast
activation and matrix deposition was demonstrated ﬁrst for skin and
mucosal wounds [50–52], and has since been shown formyoﬁbroblasts
in multiple tissues including the heart [53], lung [11,54,55], liver
[56–58], and kidney [59,60], although different amounts of force may
be required in different tissues and different contexts. In the case of
matrix stiffness, increased stiffness results in increased α-SMA expres-
sion and matrix deposition, potentially as part of a positive feedback
loop. Whether the reverse occurs is not clear: some in vitro studies,
including studies with ﬁbroblasts from patients with idiopathic pulmo-
nary ﬁbrosis, show that substrate softening results in the reversion
of myoﬁbroblasts to non-ﬁbrogenic cells [61,62], while other work sug-
gests that myoﬁbroblasts have a “mechanical memory” and retain their
phenotype even after changes in the stiffness of their surroundings [54].
Most studies of the role of stiffness inmyoﬁbroblast differentiation have
been carried out using artiﬁcial two-dimensional substrates; neither the
effects of using three-dimensional systems nor the effects of viscoelastic
or non-ideal elastic substrates are well characterized. A recent intrigu-
ing study of mesenchymal stem cells in culture showed that, when
the elastic modulus was held constant, changes in substrate viscosity
had a signiﬁcant impact on cell behavior, including morphology, prolif-
eration, andα-SMA expression [5]. Given that tissues are viscoelastic, it
will be important to carry out similar studies exploring the effects of
viscosity on myoﬁbroblasts and their precursors.
Tension in response to matrix stiffness is not the only force that
causes precursor cells to becomemyoﬁbroblastic and ﬁbrogenic. Hydro-
static pressure, which can occur within a tumor or edematous tissue, for
example, enhancesmyoﬁbroblast differentiation. Relevant to ﬁbrosis, in-
creased hydrostatic pressure resulted in themyoﬁbroblastic activation of
pancreatic and hepatic stellate cells in vitro [63,64].
Stretch also regulatesmyoﬁbroblast behavior [51]. Mouse skin, which
was stretched, showed increased numbers ofmyoﬁbroblasts [51]. In lung
ﬁbroblasts, stretch induced production of hyaluronic acid, which led to
activation of the innate immune response [65]. A new method enabling
the simultaneous study of stiffness and stretch suggested that stretch
could overcome the effects of softness and that stiffness and stretch
sensing employs similar mechanotransduction pathways to similar effect
[66]. Interestingly, however, cyclic stretch, which is typical of the normal
lung and which is decreased in ﬁbrosis, inhibited the differentiation of
lung myoﬁbroblasts [67].
Finally, ﬂuid ﬂow, including vascular ﬂow and interstitial ﬂuid ﬂow,
can also regulate the myoﬁbroblast phenotype [23,30,68]. The time
course over which ﬂow-related shear forces act on myoﬁbroblast
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Fig. 2. The role of mechanics in TGF-β activation. TGF-β is released in latent form, enclosed within the latency-associated peptide (LAP) as part of the TGF-β latent complex. Cell
surface integrins, which connect to cytoplasmic actins at the site of focal adhesions, bind to LAP. As shown by Hinz and colleagues [36,37], on soft surfaces (left) there is minimal
resistance to cell generated tension and the complex remains latent. On stiff surfaces (right), there is signiﬁcant resistance to cell-generated tension, this tension increases, and the
LAP is pulled open, releasing active TGF-β.
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tion or whether persistent changes in ﬂow are required. The observation
that alterations in both vascular and interstitial ﬂow result in a similar
myoﬁbroblastic phenotype, however, suggests that cells constitutively
sample the mechanics of their environment and may be sensitive to
changes in ﬂow rather than to absolute ﬂow rates.
7. The effects ofmechanical forces onnon-ﬁbrogenic cells inﬁbrosis
Although myoﬁbroblasts are the primary matrix-depositing cells
in tissue ﬁbrosis, other cells also participate in the development and
progression of ﬁbrosis and are similarly responsive to mechanical
forces. Chief among these are cells of the vasculature. Angiogenesis
and ﬁbrosis often progress in parallel, and may positively regulate
each other. Two- and three-dimensional angiogenesis assays show
that stiffness regulates the dynamics of tube formation [69–71] and
more speciﬁcally regulates transcriptional pathways that control angio-
genesis [72]. Liver sinusoidal endothelial cells, which are key cells in
the development of liver ﬁbrosis, demonstrate stiffness-dependent
changes in podosomes [73], which regulate adhesion and migration,
and alterations in the stiffness of glomerular podocytes are associat-
ed with renal disease [74]. In in vitro models, vascular endothelial cell
contractility and permeability increased with increasing matrix stiffness,
enhancing leukocyte extravasation; this could be important to ﬁbrosis-
associated inﬂammation (although it was not studied directly) [75–77].
Mechanical forces regulate other cell types as well. Macrophages,
which mediate ﬁbrosis in multiple organs, demonstrate phenotypic,
transcriptional, and functional changes in response to altered matrix
stiffness [78]. Stem cells, which are an important part of the response
to injury, are also increasingly recognized as being mechanosensitive
[79–81].
8. The effects of forces on architectural remodeling
Mostwork onmechanics inﬁbrosis has focused on the effects of forces
on single cells. Not yet studied in detail is the role of mechanics in the
large-scale architectural remodeling associated with ﬁbrosis. Pioneering
in vitro work by Harris [82,83] and Grinnell [84] provides potential me-
chanical explanations for large-scale architectural arrangements in tis-
sues and may be applicable to ﬁbrosis — for example, to explain the
development of bridging ﬁbrosis in the liver or of the similarly complex
reticular pattern of ﬁbrosis in idiopathic pulmonary ﬁbrosis [85]. Harris
and Grinnell found that embedding stiff, ﬁbroblast-containing implants
in soft collagen gel resulted in realignment of collagen ﬁbrils along the
axes connecting implants, with shortening of the axes and migration of
cells across the newly aligned collagen ﬁbril bridges [82–84]. Mechanisti-
cally, the investigators suggested that the stiffness of the implants led toenhanced contractility of embedded ﬁbroblasts, and that this cellular
contractility enabled alignment of intervening collagen ﬁbrils, with cell-
generated tension leading to shortening of the implant-to-implant dis-
tance. More recently, Janmey's group has shown that the non-linear elas-
tic properties of certain matrix proteins (including ﬁbrin) enable cells to
inﬂuence neighboring cells hundreds of microns away [2]. Collectively,
these observations suggest that extracellular matrix (ECM) remodeling
and reciprocal interactions between cells and the remodeled ECM, even
over long ranges, may be central to the progression of ﬁbrotic disease.
Key features of these models are that myoﬁbroblasts are con-
tractile in stiff environments and that tissue stiffness is heteroge-
neous. This has been shown experimentally for the lung and liver.
Myoﬁbroblasts from both tissues demonstrate increased contractility
on stiffer substrates in vitro [43] (and unpublished work), and both tis-
sues are mechanically heterogeneous in the normal and ﬁbrotic states.
Atomic force microscopy measurements of bleomycin-treated lung tis-
sue demonstrated marked overall increases in stiffness after
injury, focal areas of signiﬁcantly higher stiffness, and increased hetero-
geneity [11], while microindentation methods demonstrated similar
increases in mechanical heterogeneity in carbon tetrachloride-treated
livers [86]. A challenge of future research will be to incorporate these
observations into regional and tissue-scale models of ﬁbrosis and to
similarly incorporate other forces (including those from ﬂuid ﬂow and
hydrostatic pressure) into the models.
In one approach to using mechanics to model tissue behavior in
ﬁbrosis, Bates and Suki proposed that the concept of “percolation” –
transmission of events across networks – might be important in
understanding lung ﬁbrosis [87,88]. They highlight the concept of a
“percolation threshold,” which occurs when isolated ﬁbrotic lesions
connect to form a contiguous septum, resulting in a sudden increase
in macroscopic stiffness (and in symptoms). Although this work was
based on computationalmodels andwas highly simpliﬁed, examination
of human tissues provided support for the model, which, akin to the
work ofHarris andGrinnell, emphasizes the importance of geographical
variation and heterogeneity in ﬁbrosis progression [88]. The authors
also proposed that limited but targeted antiﬁbrotic therapy might be
an effective treatment for tissue ﬁbrosis, a so-called “reverse percola-
tion” effect [87].9. Matrix proteins and tissue mechanics
The matrix and mechanics are inextricably intertwined in injured
and ﬁbrotic tissues. The matrix determines the mechanical tension
and stretch sensed by cells, regulates tissue resistance to hydrostatic
pressure, andmediates interstitial ﬂuid ﬂow. Speciﬁc matrix molecules,
in particular the load-bearingmatrix proteins, have speciﬁc roles in the
mechanical environment. The collagens (with non-linear stress–strain
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erties) resilience, and the proteoglycans, resistance to compression and
shear [6,89]. Importantly, however, we do not yet understand what
speciﬁcally causes altered mechanics (especially altered stiffness)
in diseased tissue—whether cells, speciﬁc matrix proteins, or specif-
ic protein modiﬁcations are responsible.
Increased deposition of the ﬁbrillar collagens (especially collagens I
and III) is typical of tissue ﬁbrosis, and these collagens add stiffness to
tissues. Given their rigid, rod-like shape, they can also undergo align-
ment (to form parallel arrays) when subject to various forces; this
may be important to cell migration, angiogenesis, and the exposure of
cells to ﬂow, and may permit long-distance transmission of forces
[2,30,90]. Data from the cancer literature suggest that aligned collagen
ﬁbrils serve as “tracks” for cell metastases [91], and it is possible that
in ﬁbrosis these ﬁbrils have a similar role in facilitating migration of
myoﬁbroblasts or vascular cells.
As noted above, collagen cross-linking enzymes appear to play a
critical role in ﬁbrosis, likely through their effects on mechanics. In
vitro analyses demonstrate that collagen cross-linked through the
actions of lysyl oxidase is stiffer than non-cross-linked collagen
[17]. Increased liver stiffness early after injury is associated with in-
creases in lysyl oxidase-mediated collagen cross-linking andwith tissue
mechanical properties typical of a cross-linked matrix; inhibiting lysyl
oxidase activity blunts changes in stiffness, reduces myoﬁbroblast
differentiation, and partially prevents ﬁbrosis [14,16,92,93]. Tissue
transglutaminases also cross-link collagens. Although some investigators
suggest that tissue transglutaminases are responsible for the protease-
resistant cross-links of liver cirrhosis [94], others have found no role for
these cross-linking enzymes in the progression of advanced liver ﬁbrosis
[95]. Thus, the role of transglutaminase-mediated cross-links in tissue
mechanics and ﬁbrosis remains to be determined. [Lysyl oxidases in
ﬁbrosis are discussed in detail in the previous chapter.]
The other major structural proteins upregulated in ﬁbrosis, the
elastins, contribute resilience, as opposed to rigidity, to tissues
[96,97]. Like the collagens, elastins undergo cross-linking initiated by
lysyl oxidases, although the mechanical ramiﬁcations of this are not
known. The relevance of elastin cross-linking is likely to be particularly
important in lung ﬁbrosis.
Proteoglycans, which make up most of the “ground substance” be-
tween cells, also inﬂuence the mechanical properties of normal and
ﬁbrotic tissues. The glycosaminoglycan chains attached to the core pro-
teins of proteoglycans are characterized by closely-packed negative
charges, enabling them to generate electrostatic repulsive forces and
to increase their hydration. In the lung (and likely other tissues as
well), the resulting resistance to compression contributes to tissue me-
chanics by stabilizing the network of collagen and elastin ﬁbrils [98].
The small leucine-rich proteoglycans, including lumican, ﬁbromodulin,
and decorin, regulate the assembly and alignment of collagen ﬁbrils
[99,100] and may alter collagen ﬁbril mechanics [99,101,102]. Expres-
sion of the small leucine-rich proteoglycan biglycan was signiﬁcantly
correlated with changes in lung mechanics, including resistance and
compliance, in a bleomycin model of lung ﬁbrosis, with mechanical
changes identiﬁed before collagen deposition [103]. Liver ﬁbrosis in re-
sponse to injury was reduced in both lumican and ﬁbromodulin null
mice, although themechanics of the knockout liverswere not examined
[104,105]. Larger proteoglycans such as versican, as well as the glycos-
aminoglycan hyaluronic acid, resist compressive forces and regulate in-
terstitial ﬂow. Additionally, the glycocalyx, ofwhich proteoglycans are a
part, may mediate mechanotransduction [23].
The ﬁbronectins are a ﬁnal major component of the ﬁbrotic matrix.
Fibronectins are among the ﬁrst matrix proteins upregulated after
injury and are highly mechanosensitive. Fibronectin is remarkably ex-
tensible, with a highly non-linear stress–strain curve, and is able to
tolerate very high strains without breaking [106]. On stiff substrates, it
becomes very rigid, with the expression of cryptic epitopes [107]; rigid-
ity may therefore lead to changes in integrin binding and signaling.Cell-generated tension, which increases in ﬁbrosis, is critical to ﬁbro-
nectin unfolding and self assembly [108]. Additionally, cellularﬁbronec-
tin splice variants, which have insertions, are dramatically upregulated
in ﬁbrosis [109]. Although these have not been studied in detail, the in-
sertion of these extra domains may alter the mechanical properties of
the ﬁbronectins and thereby the mechanical milieu of a given tissue.
10. Summary
Mechanical forces are increasingly appreciated to play a role in
ﬁbrosis on a par with soluble factors. Matrix stiffness is so far the
best-appreciated mechanical stimulus in ﬁbrosis, and the liver and
lung are the tissues best studied. Even for these tissues and stimuli,
our understanding of forces, their effects, and mechanotransduction in
ﬁbrosis is rudimentary. Future work will need to expand our under-
standing of the variety and magnitude of forces, the characteristics of
those forces in biological tissues, and their impact on ﬁbrosis inmultiple
tissues. Ultimately, the mechanical features of ﬁbrosis may prove to be
attractive targets for antiﬁbrotic therapies.
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